Lemonaid Health vs Oak Longevity: Which GLP-1 Provider Is Better?

By Iacob Pastina, Independent Researcher

49 providers verified independently·Independent research·How we rank →

Oak Longevity beats Lemonaid Health overall, scoring 7.5/10 vs 7.2/10. Oak Longevity is more affordable at $130/mo vs $248/mo. Choose Lemonaid Health for users who want a flexible membership with broad medication o. Choose Oak Longevity for budget-conscious users who want one of the cheapest compound.

A side-by-side comparison of Lemonaid Health and Oak Longevity covering pricing, scores, medication types, insurance, and more to help you decide.

Lemonaid Health

#43 of 49

7.2/10

Established telehealth platform (acquired by 23andMe) restructured in 2026: $49/mo Weight Loss Membership + medication billed separately. Menu now includes compounded sema and tirz, compounded microdoses ($199), and brand-name Zepbound via LillyDirect ($299-449).

Visit Lemonaid Health

Higher Rated

Oak Longevity

#26 of 49

7.5/10

Telehealth platform offering compounded semaglutide and tirzepatide at the lower end of market pricing, alongside an oral Wegovy option, brand-name FDA-approved GLP-1s, and a longevity stack (NAD+, Glutathione, Sermorelin, Tesamorelin). Distinctive non-subscription billing — patients pay each month manually rather than auto-renew.

Visit Oak Longevity

Feature	Lemonaid Health	Oak Longevity
Our Score	7.2/10	7.5/10
Starting Price	$248/mo	$130/mo
Medication Type	Both	Both
Insurance Accepted	No	No
Best For	Users who want a flexible membership with broad medication options — $49/mo platform fee + compounded ($199), microdose ($199), or brand-name Zepbound via LillyDirect ($299-449)	Budget-conscious users who want one of the cheapest compounded GLP-1 entries plus a no-subscription billing model and a longevity-stack add-on (NAD+, Sermorelin)
Ranking	#43	#26

Pros & Cons Compared

Lemonaid Health

Pros

+2026 restructure — $49/mo Weight Loss Membership (replaces the old $25/visit model)
+6-month plan discount — compounded tirzepatide drops to $229/mo on a 6-month commitment
+Wide medication menu: compounded sema, compounded tirz, compounded microdoses ($199), brand-name Zepbound via LillyDirect ($299-449), and metformin
+Established since 2013 with physician-only prescribing and rigorous intake

Cons

−Membership and medication billed separately — the $49/mo number is just the membership, not all-in
−Brand-name Wegovy ($1,599) and Ozempic ($1,199) cash prices are high — read as access, not value
−Best compounded pricing requires a 6-month commitment
−The 23andMe acquisition created some uncertainty about the platform's long-term focus

Oak Longevity

Pros

+$130/mo for compounded semaglutide is among the cheapest entries on the market — Sprout Health ($99) is lower, but Oak undercuts most mid-tier platforms
+Compounded tirzepatide at $199/mo is competitively priced for a GLP-1+GIP dual agonist
+No-subscription model — patients are not auto-charged each month, choose to renew manually. Reduces unwanted recurring charges
+Broadest medication mix on the platform: compounded sema + tirz, oral Wegovy, brand Wegovy/Ozempic/Zepbound/Mounjaro, plus longevity peptides (NAD+, Glutathione, Sermorelin, Tesamorelin)
+Money-back guarantee if not approved by physician — useful safety net for borderline-eligibility patients
+Free shipping and free health coaching included in every program

Cons

−Brand-name pricing ($1,200-$1,500/mo) is significantly above market — NovoCare direct pricing for Wegovy is $349/mo, LillyDirect Zepbound $299/mo. Never buy brand-name through Oak
−No published lab panels, no specialty (obesity medicine) physicians disclosed — clinical depth is shallow
−'Up to 50% cheaper than competitors' marketing claim is unverified and inconsistent — depends on which competitor and which medication tier
−'Longevity' framing pushes users toward add-on products (NAD+, Sermorelin, Tesamorelin) that have limited clinical evidence for weight loss specifically
−Newer brand without disclosed company history, founding date, or executive team on landing pages
−Three-month plans are billed upfront — pricing transparency is good, but commit-up-front is a friction point for users testing the platform

Our Verdict

Oak Longevity edges out Lemonaid Health with a score of 7.5/10 vs 7.2/10. If budget is your priority, Oak Longevity starts at $130/mo compared to Lemonaid Health's $248/mo. Choose Lemonaid Health if you want: users who want a flexible membership with broad medication options — $49/mo platform fee + compounded ($199), microdose ($199), or brand-name zepbound via lillydirect ($299-449). Choose Oak Longevity if you want: budget-conscious users who want one of the cheapest compounded glp-1 entries plus a no-subscription billing model and a longevity-stack add-on (nad+, sermorelin).

Still undecided? Editor's #1 Overall Pick

Embody

$299/mo · 7.3/10 · Compounded

If neither Lemonaid Health nor Oak Longevity feels like the right fit, our overall #1 pick across all 49 GLP-1 telehealth providers is Embody — strongest balance of clinical oversight, transparent pricing, and verified availability.

Visit Embody→Read our full Embody review